Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02964013
Recruitment Status : Active, not recruiting
First Posted : November 15, 2016
Last Update Posted : April 25, 2022
Information provided by (Responsible Party):
Merck Sharp & Dohme LLC